Anders D. Hove is Director at Anacor Pharmaceuticals, Inc. (ANAC). They have made 17 open-market trades across 6 companies since 2006, most recently 2016-06-24.
CIK 0001411158
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $20.6M since 2006, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAC | SELL | 2016-05-16 | 2016-05-18 | $99.59 | $70.5M | -0.3% | -0.4% | -0.4% |
| ANAC | SELL | 2016-04-08 | 2016-04-11 | $70.05 | $271K | -3.2% | +0.7% | +52.5% |
| ANAC | SELL | 2016-04-07 | 2016-04-11 | $71.10 | $16.3M | -3.2% | +0.7% | +52.5% |
| ANAC | SELL | 2016-04-07 | 2016-04-11 | $71.12 | $16.0M | -3.2% | +0.7% | +52.5% |
| ANAC | SELL | 2015-12-15 | 2015-12-17 | $111.25 | $100.1M | -19.4% | -18.1% | -45.6% |
| ANAC | SELL | 2015-12-11 | 2015-12-15 | $117.36 | $4.7M | -19.4% | -16.1% | -39.7% |
| ANAC | SELL | 2015-11-10 | 2015-11-12 | $103.60 | $10.4M | -19.4% | +2.3% | -39.0% |
| EDGE | BUY | 2015-10-06 | 2015-10-08 | $11.00 | $5.0M | -3.7% | +0.9% | +12.0% |
| ANAC | SELL · 10b5-1 | 2014-09-26 | 2014-09-30 | $25.00 | $500K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2014-09-18 | 2014-09-22 | $24.87 | $18.4M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL · 10b5-1 | 2014-09-12 | 2014-09-16 | $24.99 | $2.2M | -19.4% | +2.3% | +2.3% |
| AAVL | BUY | 2014-08-05 | 2014-08-07 | $17.00 | $6.8M | N/A | N/A | N/A |
| ANAC | SELL | 2013-11-15 | 2013-11-19 | $14.06 | $2.1M | -19.4% | +2.3% | +2.3% |
| ANAC | SELL | 2012-09-20 | 2012-09-24 | $6.30 | $121K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL | 2012-09-14 | 2012-09-18 | $6.51 | $228K | -19.4% | +2.3% | +2.3% |
| ANAC | SELL | 2012-09-11 | 2012-09-13 | $6.59 | $166K | -19.4% | +2.3% | +2.3% |
| ANAC | BUY | 2010-11-30 | 2010-12-02 | $5.00 | $3.0M | -19.4% | +2.3% | +2.3% |
| ALIM | BUY | 2010-04-27 | 2010-04-28 | $11.00 | $3.4M | -20.2% | +0.0% | +0.0% |
| WHRT | BUY | 2010-01-21 | 2010-01-26 | $5.15 | $2.0M | N/A | N/A | N/A |
| TRBN | BUY | 2006-10-23 | 2006-10-25 | $13.00 | $457K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.